Disease Mongering (Pseudo-Disease Promotion)
Poglobljena analiza
15-11-2012
Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences.
Poglobljena analiza
O dokumentu
Vrsta publikacije
Politično področje
Ključna beseda
- delovno pravo in delovna razmerja
- DRUŽBENA IN SOCIALNA VPRAŠANJA
- Evropska agencija za zdravila
- EVROPSKA UNIJA
- farmacevtska industrija
- farmacevtski izdelek
- institucije EU in evropska javna uprava
- javno zdravje
- navzkrižje interesov
- potrošnja
- preprečevanje bolezni
- TRGOVINA
- varstvo potrošnikov
- ZAPOSLOVANJE IN DELOVNE RAZMERE
- zdravstvena služba
- zdravstvo